by in

PTS Diagnostics will Present at the American Diabetes Association's (ADA) 76th Scientific Sessions

PTS Diagnostics will Present at the American Diabetes Association’s (ADA) 76th Scientific Sessions

Manufacturer of A1CNow+® will exhibit and present a poster at the world’s largest meeting on diabetes June 10-14 in New Orleans

Indianapolis – June 9, 2016 – PTS Diagnostics, the U.S.-based manufacturer of point-of-care blood testing devices, including the CardioChek® and A1CNow® systems, will exhibit and participate in the poster sessions at the American Diabetes Association’s (ADA) 76th Scientific Sessions held in New Orleans.

PTS Diagnostics and eTrueNorth’s poster titled “Failure of Fasting Blood Glucose Screening to Detect All Persons with Diabetes or Prediabetes” will be on display in the “Clinical Therapeutics/New Technology–Glucose Monitoring and Sensing” area in the Poster Hall on June 11 to June 13. James Anderson, MD, lead author of the presentation and PTS Diagnostics’ medical director, will be available to discuss his research on Sunday, June 12, from noon to 2:00 p.m. at the poster’s location, 864-P.

Further, Dr. Anderson will participate in a moderated poster discussion in the session titled “The Role of Glucose Testing and Variability” on Monday, June 13 from 1 to 2:00 p.m.

Attendees to the ADA Scientific Sessions can visit PTS Diagnostics in Booth #117 during the show.

“PTS Diagnostics is pleased to be contributing to the body of knowledge that strives to screen, diagnose, treat and manage diabetes,” said Dr. Anderson. “At PTS Diagnostics, our focus is to provide healthcare professionals an easy, fast and accurate way to measure A1C. Our presentation focuses on the importance of A1C screening and testing for at-risk individuals.”

At the conclusion of the ADA event (June 14), this poster presentation will be available at www.a1cnow.com.

PTS Diagnostics manufactures A1CNow+® system, a fast and easy way of obtaining accurate A1C results with just a fingerstick in just 5 minutes at the point of care. The portable, small medical device can easily be used in multiple exam rooms, is CLIAwaived, FDA-cleared and is NGSP certified. This innovative technology enables healthcare professional to communicate face-to-face with patients about their diabetes control in minutes, not days.

About PTS Diagnostics
PTS Diagnostics is an innovative global point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. The company’s name represents the three pillars upon which it has built its long-term success: People, Technology and Service. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, distributes and markets products for distribution in more than 135 countries around the world. For more information, visit www.ptsdiagnostics.com or contact Tom Wiser at 317- 870-5610 or twiser@ptsdiagnostics.com.

MKG001963 Rev. 0 6/16